SynthesisCNS drugs2025

Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.

Vivien Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.